Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6482)
All Articles published online
|
Publishing Process of This Article
|
Jun 18, 2015 (publication date) through Nov 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Chu KKW, Cheung TT. Update in management of hepatocellular carcinoma in Eastern population. World J Hepatol 2015; 7(11): 1562-1571 [PMID: 26085915 DOI: 10.4254/wjh.v7.i11.1562] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v7/i11/1562.htm |
| Number | Citing Articles |
| 1 |
Xiu-Tao Fu, Zheng Tang, Ying-Hong Shi, Jian Zhou, Wei-Ren Liu, Qiang Gao, Guang-Yu Ding, Jia-Feng Chen, Kang Song, Xiao-Ying Wang, Jia Fan, Zhen-Bin Ding. Laparoscopic Versus Open Left Lateral Segmentectomy for Large Hepatocellular Carcinoma: A Propensity Score–Matched Analysis. Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 2019; 29(6): 513 doi: 10.1097/SLE.0000000000000723
|
| 2 |
Kwang Min Kim, Dong Hyun Sinn, Sin‐Ho Jung, Geum‐Youn Gwak, Yong‐Han Paik, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh, Seung Woon Paik. The recommended treatment algorithms of the BCLC and HKLC staging systems: does following these always improve survival rates for HCC patients?. Liver International 2016; 36(10): 1490 doi: 10.1111/liv.13107
|
| 3 |
Xinjian Yan, Tianyu Wu, Mei Tang, Dongliang Chen, Meiyuan Huang, Sichun Zhou, Huihui Zhang, Xiaoping Yang, Gaofeng Li. Methylation of the ataxia telangiectasia mutated gene (ATM) promoter as a radiotherapy outcome biomarker in patients with hepatocellular carcinoma. Medicine 2020; 99(4): e18823 doi: 10.1097/MD.0000000000018823
|
| 4 |
Joseph Asemota, Mohammed Saleh, Osato Igbinovia, Danny Burns. A Concise Review on Current Trends in Imaging and Surgical Management of Hepatocellular Carcinoma. Cureus 2020; doi: 10.7759/cureus.9191
|
| 5 |
Ying-Fen Hong, Zhan-Hong Chen, Xiao-Kun Ma, Xing Li, Dong-Hao Wu, Jie Chen, Min Dong, Li Wei, Tian-Tian Wang, Dan-Yun Ruan, Ze-Xiao Lin, Jing-Yun Wen, Qu Lin, Chang-Chang Jia, Xiang-Yuan Wu. Comparison of five models for end-stage liver disease in predicting the survival rate of patients with advanced hepatocellular carcinoma. Tumor Biology 2016; 37(4): 5265 doi: 10.1007/s13277-015-4366-2
|
| 6 |
Wei Dai, Shuo Fang, Cong Mo, Yuxin Liu, Tingyun Shen, Mingyi Li, Honglian Zhou, Huilai Miao, Ming Chen, Xiaoyu Tan, Shiting Bao, Xiaohong Xu, Nianping Chen. Comparison of laparoscopic radiofrequency ablation with percutaneous radiofrequency ablation in the treatment of chronic hepatitis B-related hepatocellular carcinoma involving specific sites: A retrospective cohort study. Asian Journal of Surgery 2024; 47(1): 100 doi: 10.1016/j.asjsur.2023.04.073
|
| 7 |
Freliska Lazuardi, Jacqueline Valencia, Shusen Zheng. Adjuvant transcatheter arterial chemoembolization after radical resection of hepatocellular carcinoma patients with tumor size less than 5 cm: a retrospective study. Scandinavian Journal of Gastroenterology 2019; 54(5): 617 doi: 10.1080/00365521.2019.1607896
|
| 8 |
Sebastian Senger, Jens Sperling, Barbara Oberkircher, Martin K. Schilling, Otto Kollmar, Michael D. Menger, Christian Ziemann. Portal branch ligation does not counteract the inhibiting effect of temsirolimus on extrahepatic colorectal metastatic growth. Clinical & Experimental Metastasis 2017; 34(5): 323 doi: 10.1007/s10585-017-9852-z
|
| 9 |
Xihai Wang, Hongyuan Liang, Zaiming Lu. Efficacy of transarterial chemoembolization compared with radiofrequency ablation for the treatment of recurrent hepatocellular carcinoma after radiofrequency ablation. Minimally Invasive Therapy & Allied Technologies 2020; 29(6): 344 doi: 10.1080/13645706.2019.1649286
|
| 10 |
Chunmei Ji, Hang Liu, Qiang Yin, Hui Li, Han Gao. miR-93 enhances hepatocellular carcinoma invasion and metastasis by EMT via targeting PDCD4. Biotechnology Letters 2017; 39(11): 1621 doi: 10.1007/s10529-017-2403-5
|
| 11 |
Kevin Ka Wan Chu, Kenneth Siu Ho Chok. Is the treatment outcome of hepatocellular carcinoma inferior in elderly patients?. World Journal of Gastroenterology 2019; 25(27): 3563-3571 doi: 10.3748/wjg.v25.i27.3563
|
| 12 |
Chang‑Hua Kou, Jin Han, Xi‑Lin Han, Hui‑Jie Zhuang, Zi‑Ming Zhao. Preparation and characterization of the Adriamycin‑loaded amphiphilic chitosan nanoparticles and their application in the treatment of liver cancer. Oncology Letters 2017; doi: 10.3892/ol.2017.7210
|
| 13 |
Ling Liao, Xia Chen, Hengliu Huang, Yuwei Li, Qing Huang, Zhen Song, Jie Luo, Tao Yuan, Shaoli Deng. Long non-coding RNA CASC7 is a promising serum biomarker for hepatocellular carcinoma. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02961-7
|
| 14 |
Masaaki Hidaka, Takanobu Hara, Akihiko Soyama, Tomohiko Adachi, Hajime Matsushima, Takayuki Tanaka, Hideki Ishimaru, Hisamitsu Miyaaki, Kazuhiko Nakao, Susumu Eguchi. Long‐term outcomes of living‐donor liver transplantation, hepatic resection, and local therapy for hepatocellular carcinoma with three <3‐cm nodules in a single institute. JGH Open 2022; 6(8): 539 doi: 10.1002/jgh3.12783
|
| 15 |
Meng Niu, Duo Hong, Teng-Chuang Ma, Xiao-Wei Chen, Jin-Hang Han, Jun Sun, Ke Xu. Short-term and long-term efficacy of 7 targeted therapies for the treatment of advanced hepatocellular carcinoma. Medicine 2016; 95(49): e5591 doi: 10.1097/MD.0000000000005591
|
| 16 |
Xiu-Tao Fu, Ying-Hong Shi, Jian Zhou, Yuan-Fei Peng, Wei-Ren Liu, Guo-Ming Shi, Qiang Gao, Xiao-Ying Wang, Kang Song, Jia Fan, Zhen-Bin Ding. Association of hepatitis status with surgical outcomes in patients with dual hepatitis B and C related hepatocellular carcinoma. Infectious Agents and Cancer 2017; 12(1) doi: 10.1186/s13027-017-0137-6
|
| 17 |
Peijuan Chen, Ling Lei, Jian Wang, Xuejing Zou, Dongyan Zhang, Ling Deng, Dehua Wu. Downregulation of Talin1 promotes hepatocellular carcinoma progression through activation of the ERK1/2 pathway. Cancer Science 2017; 108(6): 1157 doi: 10.1111/cas.13247
|
| 18 |
Subbroto Kumar Saha, Hye Yeon Choi, Gwang-Mo Yang, Polash Kumar Biswas, Kyeongseok Kim, Geun-Ho Kang, Minchan Gil, Ssang-Goo Cho. GPR50 Promotes Hepatocellular Carcinoma Progression via the Notch Signaling Pathway through Direct Interaction with ADAM17. Molecular Therapy - Oncolytics 2020; 17: 332 doi: 10.1016/j.omto.2020.04.002
|